Loading clinical trials...
Loading clinical trials...
An Open-Label and Double-Blind Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Subjects With Major Depressive Disorder
Conditions
Interventions
Ketamine
Placebo
Locations
1
United States
Durham, North Carolina, United States
Start Date
February 1, 2014
Primary Completion Date
September 1, 2015
Completion Date
September 1, 2015
Last Updated
January 27, 2017
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT07329621
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions